Neogen Corporation NEOG
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +69.10%
- 1 year
- +97.00%
- Open
- 12.15
- Prev close
- 12.26
- Mkt cap
- 2.58B
- Vol
- 1.95M
- Avg vol
- 3.35M
- EPS
- -0.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.63
- High
- 12.24
- Forward P/E
- 26.03
- Beta
- 1.79
- Short ratio
- 2.26
- Inst. own
- 111.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 14, 2027
- 50-d avg
- 12.23
- 200-d avg
- 10.41
- 1y target
- 14.00
2Y chart
Events in this range
- Oct 9, 2025Earnings: 0.04; estimate -0.074; surprise 154.05%
- Dec 10, 2025Rating: CJS Securities · Market Perform → Market Outperform
- Jan 8, 2026Earnings: 0.1; estimate 0.07; surprise 42.86%
- Jan 9, 2026Rating: Guggenheim · Buy → Buy
- Jan 12, 2026Rating: Piper Sandler · Neutral → Neutral
- Apr 9, 2026Earnings: 0.09; estimate 0.04; surprise 125%
- Jul 30, 2026Earnings: 0.09; estimate 0.05667; surprise 58.81%
- Aug 3, 2026Rating: Piper Sandler · Neutral → Neutral
- Aug 26, 2026Rating: Piper Sandler · Neutral → Overweight
- Sep 30, 2026Rating: Guggenheim · Buy → Buy
- Oct 6, 2026Earnings: 0.08; estimate 0.05333; surprise 50.01%
Signals (87)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 29, 2026 | 3 days ago |
| SMA: Bearish | Oct 28, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| RSI: Overbought | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| RSI: Oversold | Mar 18, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 8 months ago |
| RSI: Overbought | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| RSI: Overbought | Jan 8, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| RSI: Overbought | Dec 18, 2025 | 10 months ago |
| RSI: Overbought | Dec 10, 2025 | 10 months ago |
| SMA: Bullish | Dec 9, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Nov 25, 2025 | 11 months ago |
| SMA: Bearish | Nov 18, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 18, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 24, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 17, 2025 | 1 year ago |
| RSI: Overbought | Oct 9, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 17, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 2, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| RSI: Oversold | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 14, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 20, 2025 | 1 year ago |
| RSI: Oversold | Feb 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 24, 2024 | 1 year ago |
Key statistics
- Market cap
- 2.56B
- Enterprise value
- 3.28B
- Trailing P/E
- 0.00
- Forward P/E
- 26.03
- PEG ratio
- 0.66
- Price / sales
- 2.89
- Price / book
- 1.23
- EPS (TTM)
- -0.26
- Beta
- 1.79
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -6.35%
- Revenue (TTM)
- 884.00M
- Revenue growth
- 6.50%
- Free cash flow
- 38.94M
- Total cash
- 172.00M
- Total debt
- 774.30M
- Return on equity
- -2.67%
- Shares outstanding
- 218.31M
- Short % of float
- 7.30%
- 50-day average
- 12.23
- 200-day average
- 10.41
Analyst view
Consensus: buy
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Jan 14, 2027
Expected Jan 14, 2027. Consensus EPS estimate 0.06333.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 14, 2027 | Nov 30, 2026 | 0.07 | — | — | — |
| Oct 6, 2026 | Aug 31, 2026 | 0.05333 | 0.08 | +0.03 | +50.01% |
| Jul 30, 2026 | May 31, 2026 | 0.05667 | 0.09 | +0.03 | +58.81% |
| Apr 9, 2026 | Feb 28, 2026 | 0.04 | 0.09 | +0.05 | +125.00% |
| Jan 8, 2026 | Nov 30, 2025 | 0.07 | 0.10 | +0.03 | +42.86% |
| Oct 9, 2025 | Aug 31, 2025 | -0.074 | 0.04 | +0.11 | +154.05% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 2026 | Guggenheim | main | Buy | Buy |
| Aug 26, 2026 | Piper Sandler | up | Neutral | Overweight |
| Aug 3, 2026 | Piper Sandler | reit | Neutral | Neutral |
| Jan 12, 2026 | Piper Sandler | reit | Neutral | Neutral |
| Jan 9, 2026 | Guggenheim | main | Buy | Buy |
| Dec 10, 2025 | CJS Securities | up | Market Perform | Market Outperform |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- neogen.com
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
- NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
- Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
- Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Your note
Sign in to keep a note on NEOG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADENT JOHN EDWARD | Former | Conversion of Exercise of derivative security | Oct 26, 2025 | 363,081 |
| BOEHM WILLIAM T | Director | Conversion of Exercise of derivative security | Oct 26, 2025 | 47,913 |
| BOREL JAMES C. | Director | Conversion of Exercise of derivative security | Oct 26, 2025 | 94,570 |
| JONES DOUGLAS EDWARD | Former | Conversion of Exercise of derivative security | Oct 26, 2025 | 100,881 |
| NAEMURA DAVID HARTMAN | Former | Conversion of Exercise of derivative security | Nov 30, 2025 | 90,388 |
| NASSIF MIKHEAL | Chief Executive Officer | Stock Award(Grant) | Aug 13, 2026 | 141,631 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.31% | 33,431,015 | 391.64M | Jun 29, 2026 |
| Neuberger Berman Group, LLC | 7.59% | 16,570,795 | 194.13M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.97% | 13,038,732 | 152.75M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 4.50% | 9,828,174 | 115.14M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.42% | 9,655,248 | 113.11M | Jun 29, 2026 |
| SG Americas Securities, LLC | 4.28% | 9,352,065 | 109.56M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 12,983,088 | 152.10M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 6,928,358 | 81.17M | Jun 29, 2026 |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 3.13% | 6,842,464 | 80.16M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.63% | 5,738,526 | 67.23M | Sep 29, 2026 |
| BARON INVESTMENT Fd.S TRT -Baron Small Cap Fd. | 2.29% | 5,000,000 | 58.58M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 4,987,158 | 58.42M | Jun 29, 2026 |